Company profile

QTNT stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

4 Feb 20
5 Jun 20
31 Mar 21

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 7.94M 7.85M 8.17M 8.28M
Net income -27.49M -26.99M -23.57M -26.59M
Diluted EPS -0.37 -0.41 -0.36 -0.39
Net profit margin -346% -344% -289% -321%
Operating income -22.36M -18.44M -18.42M -20.33M
Net change in cash -1.15M -712K 2.43M -372K
Cash on hand 4.66M 5.82M 6.53M 4.1M
Cost of revenue 4.53M 3.97M 4.56M 4.43M
Annual (USD) Mar 19 Mar 18 Mar 17 Mar 16
Revenue 29.13M 24.73M 22.23M 18.52M
Net income -105.39M -82.34M -85.07M -33.88M
Diluted EPS -1.92 -2.02 -3.02 -1.73
Net profit margin -362% -333% -383% -183%
Operating income -78.96M -69.99M -74.06M -49.09M
Net change in cash -16.07M 15.41M -39.35M 6.58M
Cash on hand 4.1M 20.17M 4.75M 44.1M
Cost of revenue 17.23M 10.47M 10.84M 9.66M

Financial data from Quotient earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
28 May 20 Stackawitz Jeremy Ordinary Shares Sell Dispose S 7.41 11,000 81.51K 142,926
28 May 20 Farrell Edward Ordinary Shares Sell Dispose S 7.4 12,811 94.8K 29,013
24 May 20 Farrell Edward Ordinary Shares Option exercise Aquire M 0 27,258 0 41,824
24 May 20 Farrell Edward RSU Ordinary Shares Grant Aquire A 0 55,000 0 55,000
24 May 20 Farrell Edward RSU Ordinary Shares Option exercise Dispose M 0 15,000 0 30,000
24 May 20 Farrell Edward RSU Ordinary Shares Option exercise Dispose M 0 12,258 0 12,257
24 May 20 Buhler Peter RSU Ordinary Shares Grant Aquire A 0 55,000 0 55,000
24 May 20 Lindop Christopher J Ordinary Shares Option exercise Aquire M 0 25,271 0 376,647
24 May 20 Lindop Christopher J RSU Ordinary Shares Option exercise Dispose M 0 15,000 0 30,000
24 May 20 Lindop Christopher J RSU Ordinary Shares Option exercise Dispose M 0 10,271 0 10,270
74.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 85 84 +1.2%
Opened positions 16 12 +33.3%
Closed positions 15 9 +66.7%
Increased positions 30 40 -25.0%
Reduced positions 22 19 +15.8%
13F shares
Current Prev Q Change
Total value 235.35M 570.04M -58.7%
Total shares 59.44M 59.69M -0.4%
Total puts 32.5K 0 +Infinity%
Total calls 57.6K 91.9K -37.3%
Total put/call ratio 0.6
Largest owners
Shares Value Change
Perceptive Advisors 13.29M $52.49M 0.0%
POLR Polar Capital 7.61M $30.06M +4.9%
AMP Ameriprise Financial 4.2M $16.61M +15.1%
Highbridge Capital Management 4.16M $16.45M +100.9%
Cormorant Asset Management 3.16M $12.49M -9.7%
Clearbridge Advisors 3.05M $12.06M +1.0%
TimesSquare Capital Management 2.92M $11.55M +60.7%
MS Morgan Stanley 2.82M $11.13M -5.1%
CS Credit Suisse 2.73M $10.79M +11.8%
Farallon Capital Management 2.5M $9.88M 0.0%
Largest transactions
Shares Bought/sold Change
Highbridge Capital Management 4.16M +2.09M +100.9%
FMR 0 -2.01M EXIT
Broadfin Capital 0 -1.99M EXIT
TimesSquare Capital Management 2.92M +1.1M +60.7%
Park West Asset Management 0 -1.03M EXIT
Schonfeld Strategic Advisors 254.95K -593.72K -70.0%
Pura Vida Investments 1.68M +590.24K +54.1%
AMP Ameriprise Financial 4.2M +552.18K +15.1%
Renaissance Technologies 535.7K +513.9K +2357.3%
First Midwest Bank Trust Division 392.07K +392.07K NEW

Financial report summary

?
Competition
MilliporeInsignia SystemsGrifols
Risks
  • Our commercialization plan for MosaiQ in the patient testing market may depend on entering into arrangements with one or more commercial partners.
Management Discussion
  • Total revenue and product sales for the quarter ended December 31, 2019 increased by 18% to $7.9 million, compared with $6.7 million for the quarter ended December 31, 2018. The increase in total revenue was due to $0.3 million of other revenues arising from the achievement of product development milestones in the quarter ended December 31, 2019 and an increase of 14% in product sales.  The increase in product sales was primarily attributable to growth in product sales to OEM customers and incremental direct sales of conventional reagent products to customers in the United States. Products sold by standing purchase order were 72% of product sales for the quarter ended December 31, 2019, compared with 67% for the quarter ended December 31, 2018.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: appointed, attempt, Boyd, Buhler, choose, deal, declaration, defend, dispute, Ernest, FidFund, fragmented, framework, infrastructure, inherent, Larnach, member, merit, overlap, Peter, proceeding, put, resign, resolution, resolving, restructuring, Roland, SA, SE, seeking, serve, social, stage, strained, Suisse, threatened, Vice, vigorously, wider
Removed: consecutive, decreased, generated, partially, reduced, Rule